Key Findings:  Current clinical studies are investigating the use of CBD in mood disorders such as anxiety, control for chronic pain, anti-inflammatory diseases, neurodegenerative diseases such as Alzheimer and Parkinson disease, and antitumorigenic properties. However, none of these trials have yet resulted in FDA approval of CBD oil to treat
Type of Study:  Meta-analysis
Study Result:  Positive
Study Location(s):  Italy
Year of Pub:  2020
Cannabinoids Studied:  Cannabidiol (CBD)
Phytocannabinoid Source:  Not Applicable
Receptors Studied:  CB1, CB2, PPAR - Gamma